N3-DAPr-Suc-OH can be used as an ADC (Antibody-Drug Conjugate) linker. It features an azide (N3) group attached to a propylenediamine (DAPr) moiety and a succinoyl (Suc) group at the end. This structure allows for the attachment of a cytotoxic payload to an antibody through the succinoyl group, while the azide group can be used for further functionalization or conjugation reactions.
Structure of 929894-58-6
* For research and manufacturing use only. We do not sell to patients.
Size | Price | Stock | Quantity |
---|---|---|---|
-- | $-- | In stock |
Looking for different specifications? Click to request a custom quote!
Capabilities & Facilities
Contact our experts today for pricing and comprehensive details on our ADC offerings.
From cytotoxin synthesis to linker design, discover our specialized services that complement your ADC projects.
Learn more about payload design, linker strategies, and integrated CDMO support through our curated ADC content.
Find exactly what your project needs from our expanded range of ADCs, offering flexible options to fit your timelines and goals.